1
Clinical Trials associated with CD19 CAR-DC(Second Affiliated Hospital, School of Medicine, Zhejiang University)Exploratory Clinical Study of CD19-targeted CAR-T and CAR-DC in the Treatment of Relapsed and Refractory B-cell Lymphoma
This is an open, single-arm, prospective, dose-escalation clinical trial designed to evaluate the safety and the preliminary efficacy of CD19-targeted CAR-T combined with CAR-DC in the treatment of relapsed and refractory B-cell lymphoma
100 Clinical Results associated with CD19 CAR-DC(Second Affiliated Hospital, School of Medicine, Zhejiang University)
100 Translational Medicine associated with CD19 CAR-DC(Second Affiliated Hospital, School of Medicine, Zhejiang University)
100 Patents (Medical) associated with CD19 CAR-DC(Second Affiliated Hospital, School of Medicine, Zhejiang University)
100 Deals associated with CD19 CAR-DC(Second Affiliated Hospital, School of Medicine, Zhejiang University)